Table 1 The demographic and baseline characteristics
Characteristics | Ceftriaxone-sulbactam | Cefoperazone-sulbactam | P |
|---|---|---|---|
Male, n(%) | 64(44.44%) | 63(44.68%) | 0.9680 |
Female, n(%) | 80(55.56%) | 78(55.32%) | |
Mean age, years(SD) | 46.00±15.86 | 46.47±14.49 | 0.9370 |
Mean weight, kg(SD) | 59.36±11.08 | 59.61±11.29 | 0.9742 |
Treatment duration | 8.45±3.03 | 8.10±3.00 | 0.3251 |
Condition | |||
Intermediate | 113 | 116 | 0.7901 |
Severe | 31 | 25 | 0.5085 |
Temperature(°C) | 37.19±0.79 | 37.04±0.77 | 0.0840 |
With underlying diseases | 34 | 29 | 0.6209 |
Type of infection, n(%) | |||
Respiratory tract infection | 0.2348 | ||
Pneumonia | 33(45.83%) | 32(44.44%) | |
Exacerbation of chronic bronchitis | 21(29.17%) | 15(20.83%) | |
Bronchiectasis | 12(16.67%) | 11(15.28%) | |
Others | 6(8.33%) | 14(19.44%) | |
Urinary tract infection | 0.8021 | ||
Acute pyelonephritis | 24(33.33%) | 19(27.54%) | |
Exacerbation of chronic pyelonephritis | 9(12.50%) | 7(10.14%) | |
Acute cystitis | 33(45.83%) | 37(53.62%) | |
Others | 6(8.33%) | 6(8.70%) |